ABSTRACT
INTRODUCTION
Cabanas in 1977 originally was defining sentinel lymph node in penile cancer patients. Already at this time lymph drainage imaging in melanoma has been done in many centers including ours to define the drainage of lymph flow without recognizing its unique clinical relevance. The unique concept says that a histologically negative sentinel lymph node predicts that the remaining lymph nodes will be tumor free. The reliability of this concept has been assessed in melanoma (Morton et al., 1992) and breast cancer patients (Cox et al., 1988 ) so far and is currently applied for a variety of other tumors such as in the maxillofacial region (Hyde et al., 2002) , colorectal (Basilio et al., 2006) , breast (Frisell et al., 2001 ), esophageal and gastric (Kitagawa et al., 2005) , cervical (Hubalewska et al., 2003 ), vulvar (De Hullu et al., 2000 and penile (Valdés Olmos et al., 2001) cancer. We are reporting our experience with vulvar and cervical cancer. We performed the first vulvar cancer sentinel node scintigraphy in 1999 (Granegger et al., 1999) and cervical in 2001 (Sinzinger and Meghdadi, 2001) , preliminary data were published in 2002.
PATIENTS AND METHODS
Patients (T1, T2) received a total of 12 MBq Tc-nanocolloid (GE Healthcare Buchlar GmbH and Co.KG, Braunschweig, Germany) in 1 ml saline intradermally divided in 4 parts in each quadrant around the tumor using an insulin syringe (BD 1 ml syringe, Luer-Lok TM Tip; BD, New Jersey, USA). In cervical cancer 0.5 -1.5 ml were used. Lymphoscintigraphy was performed with a double-headed gamma camera using a low energy high resolution collimator. Static images were performed at 5, 30, 60 and 90 minutes after tracer application. If possible, the sentinel was marked on the skin and the gamma camera images were available to the surgeon before starting the operation. Histopathological examination of the sentinel node and the other nodes was done after hematoxylin/eosine staining and serial sectioning. Nodes initially were cut into 2 to 3 mm slices and then each block again at 400 µ distance. The count rate in-vivo and in-vitro was measured, localization and count rate of all suspected sentinel nodes was documented. Radioactive nodes were separated and lymph node dissection performed. In negative sentinel nodes additional immunohistochemical examination was done.
RESULTS
Sentinel nodes appear mainly on the ipsi-lateral (tumor) side. From the ones showing up immediately presenting 1 sentinel only (n = 24, 22.86%), the overwhelming majority (n = 22, 22.95%) appeared on the ipsilateral side (Table 2) . Only in 4 cases there were more than 2 sentinels showing up immediately on the ipsilateral side, no one at the contralateral side. In 5 patients (4.76%) a sentinel node was found up to 30 minutes, in 1 (0.95%) at 60 minutes. A total of 22 sentinel nodes (20.95%) were showing up as late as after 30 minutes, 7 others (6.67%) even later at 60 minutes. 22 patients (20.95%) showed 1 sentinel node immediately on both sides. In the other patients a variety of combinations was seen concerning site, number and time of appearance. In 6 patients a clear transport along the lymph vessel was discovered. The maximal number of sentinels seen in one patient was 5; 3 patients also presenting the primary tumor more than 1 cm from the midline, exhibited a sentinel node on the contralateral side, one of them showing even 2 nodes. Cervical cancer sentinel nodes present mainly bilateral along the pelvic wall and next to the cervix (table 3) , while in those cases with unilateral appearance sentinel localization next to the cervix is predominant. 
DISCUSSION
Sentinel lymph node scintigraphy is now widely performed for both, vulvar cancer (De Hullu et al., 2000) and cervical cancer (Van de Lande et al., 2007) . Wydra et al. (2003) found that the superficial administration of the radiocolloid into the cervix provides a higher sentinel node detection rate compared to deeper administration, a fact we can strongly support. All the negative images in the learning phase apparently were due to inappropriate administration. In order to avoid false negative imaging, strictly intradermal injection combined with an at least 60 minutes follow-up and a trained, experienced team are key requirements. From the point of the application technique, both vulvar and cervical cancer are probably the most difficult ones. Hauspy et al. (2008) found that in vulvar cancer being at least 1 cm from the midline no contralateral sentinel node appeared, a finding we were unable to confirm. In contrast to Hauspy we found a higher rate of bilateral nodes (67.62% vs. 46%). Overall, vulva sentinel shows excellent findings.
Various authors with significant number of cases (Louis-Sylvestre et al., 2005 , Moore et al., 2003 , Hauspy et al., 2008 , De Hullu et al., 2000 reported no false negative node. Vulva sentinel is probably one of the most relevant ones combining reduction of postoperative morbidity of these mainly older aged patients with excellent results. 
RESUMO

